CORT logo

CORT EBITDA

Annual EBITDA

$138.29 M
+$28.64 M+26.12%

December 31, 2024

Summary

Performance

1-Year Change

+26.12%

3-Year Change

+8.08%

5-Year Change

+21.54%

15-Year Change

+161.11%

CORT EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

88.1%
CORT annual EBITDA is higher than 88.1% of companies in Healthcare sector

High & Low

All-time High

$138.29 M
CORT annual EBITDA is currently at an all-time high

3-Year Low

$109.64 M
CORT annual EBITDA is currently +26.12% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
CORT previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
CORT next annual earnings announcement has not yet been scheduled

OtherCORTprofitabilitymetrics:

Annual Revenue

$675.04 M
CORT annual revenue is $675.04 million

Annual Net Income

$141.21 M
CORT annual net profit is $141.21 million

Annual EBIT

$136.95 M
CORT annual earnings before interest & taxes is $136.95 million

Annual EPS

$1.23
CORT annual earnings per share is $1.23

Quarterly EBITDA

$25.72 M
-$21.38 M-45.39%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

-19.47%

3-Year Change

-19.47%

5-Year Change

-19.47%

CORT Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

86.45%
CORT quarterly EBITDA is higher than 86.45% of companies in Healthcare sector

High & Low

All-time High

$47.10 M
CORT quarterly EBITDA is currently -45.39% below its historical high of $47.10 million

3-Year Low

$15.71 M
CORT quarterly EBITDA is currently +63.71% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
CORT previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 1, 2025
CORT next earnings announcement is scheduled for May 1, 2025

OtherCORTprofitabilitymetrics:

Quarterly Revenue

$181.89 M
CORT quarterly revenue is $181.89 million

Quarterly Net Income

$30.75 M
CORT quarterly net profit is $30.75 million

Quarterly EBIT

$25.26 M
CORT quarterly earnings before interest & taxes is $25.26 million

Quarterly EPS

$0.26
CORT quarterly earnings per share is $0.26

TTM EBITDA

$138.29 M
-$6.22 M-4.30%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+26.12%

3-Year Change

+26.12%

5-Year Change

+26.12%

CORT TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

87.55%
CORT TTM EBITDA is higher than 87.55% of companies in Healthcare sector

High & Low

All-time High

$144.51 M
CORT TTM EBITDA is currently -4.30% below its historical high of $144.51 million

3-Year Low

$101.43 M
CORT TTM EBITDA is currently +36.34% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
CORT previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 1, 2025
CORT next earnings announcement is scheduled for May 1, 2025

OtherCORTprofitabilitymetrics:

TTM Revenue

$675.04 M
CORT TTM revenue is $675.04 million

TTM Net Income

$141.21 M
CORT TTM net profit is $141.21 million

TTM EBIT

$136.95 M
CORT TTM earnings before interest & taxes is $136.95 million

TTM EPS

$1.24
CORT TTM earnings per share is $1.24

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$138.29 M
CORT annual EBITDA is $138.29 million

Annual Net Income

$141.21 M
CORT annual net profit is $141.21 million

Annual Interest Expense

-
CORT annual interest expense value is unknown

Annual Income Tax

$20.28 M
CORT annual income tax is $20.28 million

Annual D&A

$1.34 M
CORT annual depreciation & amortization is $1.34 million

CORT EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+26.1%-19.5%+26.1%
3 y3 years+8.1%-19.5%+26.1%
5 y5 years+21.5%-19.5%+26.1%

CORT EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+26.1%-45.4%+63.7%-4.3%+36.3%
5 y5-yearat high+26.1%-45.4%+63.7%-4.3%+36.3%
alltimeall timeat high+433.9%-45.4%+300.5%-4.3%+419.2%

Corcept Therapeutics Incorporated EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
$138.29 M(+26.1%)
$25.72 M(-45.4%)
$138.29 M(-4.3%)
Sep 2024
-
$47.10 M(+31.6%)
$144.51 M(+12.1%)
Jun 2024
-
$35.79 M(+20.6%)
$128.88 M(+4.3%)
Mar 2024
-
$29.68 M(-7.1%)
$123.61 M(+12.7%)
Dec 2023
$109.64 M(-5.5%)
$31.94 M(+1.5%)
$109.64 M(+8.1%)
Sep 2023
-
$31.47 M(+3.1%)
$101.43 M(-1.2%)
Jun 2023
-
$30.52 M(+94.3%)
$102.65 M(-1.5%)
Mar 2023
-
$15.71 M(-33.8%)
$104.22 M(-10.2%)
Dec 2022
$116.08 M(-9.3%)
$23.72 M(-27.4%)
$116.08 M(-10.9%)
Sep 2022
-
$32.69 M(+1.8%)
$130.23 M(-3.2%)
Jun 2022
-
$32.10 M(+16.4%)
$134.54 M(-0.4%)
Mar 2022
-
$27.57 M(-27.2%)
$135.14 M(+5.6%)
Dec 2021
$127.95 M(-1.9%)
$37.87 M(+2.3%)
$127.95 M(+5.6%)
Sep 2021
-
$37.00 M(+13.2%)
$121.16 M(+10.7%)
Jun 2021
-
$32.70 M(+60.4%)
$109.44 M(-2.7%)
Mar 2021
-
$20.38 M(-34.4%)
$112.51 M(-13.7%)
Dec 2020
$130.44 M(+14.6%)
$31.07 M(+22.9%)
$130.44 M(-3.3%)
Sep 2020
-
$25.28 M(-29.3%)
$134.94 M(-5.8%)
Jun 2020
-
$35.77 M(-6.6%)
$143.24 M(+8.0%)
Mar 2020
-
$38.31 M(+7.7%)
$132.63 M(+16.6%)
Dec 2019
$113.78 M(+26.8%)
$35.58 M(+6.0%)
$113.78 M(+10.3%)
Sep 2019
-
$33.58 M(+33.5%)
$103.17 M(+11.4%)
Jun 2019
-
$25.16 M(+29.3%)
$92.62 M(+5.1%)
Mar 2019
-
$19.46 M(-22.0%)
$88.15 M(-1.8%)
Dec 2018
$89.73 M(+69.4%)
$24.97 M(+8.4%)
$89.73 M(+3.7%)
Sep 2018
-
$23.03 M(+11.3%)
$86.51 M(+12.1%)
Jun 2018
-
$20.69 M(-1.7%)
$77.14 M(+11.4%)
Mar 2018
-
$21.04 M(-3.2%)
$69.25 M(+30.8%)
Dec 2017
$52.96 M(+415.9%)
$21.75 M(+59.2%)
$52.96 M(+46.1%)
Sep 2017
-
$13.66 M(+6.7%)
$36.24 M(+41.2%)
Jun 2017
-
$12.80 M(+169.4%)
$25.67 M(+78.3%)
Mar 2017
-
$4.75 M(-5.4%)
$14.40 M(+40.3%)
Dec 2016
$10.27 M(-412.2%)
$5.02 M(+62.4%)
$10.27 M(+48.3%)
Sep 2016
-
$3.09 M(+101.9%)
$6.92 M(+74.7%)
Jun 2016
-
$1.53 M(+147.5%)
$3.96 M(+199.9%)
Mar 2016
-
$619.00 K(-63.1%)
$1.32 M(-140.2%)
Dec 2015
-$3.29 M(-88.0%)
$1.68 M(+1172.0%)
-$3.29 M(-58.9%)
Sep 2015
-
$132.00 K(-111.9%)
-$8.01 M(-39.4%)
Jun 2015
-
-$1.11 M(-72.2%)
-$13.20 M(-29.2%)
Mar 2015
-
-$3.99 M(+31.3%)
-$18.64 M(-32.2%)
Dec 2014
-$27.48 M(-33.7%)
-$3.04 M(-40.0%)
-$27.48 M(-20.2%)
Sep 2014
-
-$5.06 M(-22.6%)
-$34.45 M(-11.9%)
Jun 2014
-
-$6.54 M(-49.0%)
-$39.10 M(-9.7%)
Mar 2014
-
-$12.83 M(+28.2%)
-$43.32 M(+4.6%)
Dec 2013
-$41.42 M
-$10.01 M(+3.0%)
-$41.42 M(+0.1%)
DateAnnualQuarterlyTTM
Sep 2013
-
-$9.72 M(-9.7%)
-$41.38 M(+5.2%)
Jun 2013
-
-$10.76 M(-1.5%)
-$39.33 M(+8.8%)
Mar 2013
-
-$10.93 M(+9.7%)
-$36.15 M(-0.3%)
Dec 2012
-$36.24 M(+12.1%)
-$9.97 M(+30.0%)
-$36.24 M(+0.1%)
Sep 2012
-
-$7.67 M(+1.0%)
-$36.20 M(+3.5%)
Jun 2012
-
-$7.59 M(-31.2%)
-$34.97 M(-3.5%)
Mar 2012
-
-$11.03 M(+11.1%)
-$36.26 M(+12.2%)
Dec 2011
-$32.33 M(+24.6%)
-$9.92 M(+54.2%)
-$32.33 M(+12.5%)
Sep 2011
-
-$6.44 M(-27.4%)
-$28.73 M(-2.3%)
Jun 2011
-
-$8.87 M(+25.0%)
-$29.40 M(+9.0%)
Mar 2011
-
-$7.10 M(+12.2%)
-$26.97 M(+4.0%)
Dec 2010
-$25.93 M(+28.1%)
-$6.33 M(-10.9%)
-$25.94 M(+4.7%)
Sep 2010
-
-$7.10 M(+10.3%)
-$24.77 M(+10.9%)
Jun 2010
-
-$6.44 M(+6.3%)
-$22.33 M(+7.5%)
Mar 2010
-
-$6.06 M(+17.4%)
-$20.77 M(+2.6%)
Dec 2009
-$20.24 M(+2.9%)
-$5.16 M(+10.6%)
-$20.24 M(-4.0%)
Sep 2009
-
-$4.67 M(-4.4%)
-$21.09 M(-1.1%)
Jun 2009
-
-$4.88 M(-11.8%)
-$21.32 M(+0.9%)
Mar 2009
-
-$5.53 M(-8.0%)
-$21.13 M(+7.4%)
Dec 2008
-$19.68 M(+60.9%)
-$6.01 M(+22.8%)
-$19.68 M(+8.8%)
Sep 2008
-
-$4.90 M(+4.6%)
-$18.08 M(+7.7%)
Jun 2008
-
-$4.68 M(+14.8%)
-$16.79 M(+22.7%)
Mar 2008
-
-$4.08 M(-7.6%)
-$13.69 M(+11.9%)
Dec 2007
-$12.23 M(-52.2%)
-$4.42 M(+22.2%)
-$12.23 M(+3.6%)
Sep 2007
-
-$3.61 M(+129.3%)
-$11.80 M(-19.9%)
Jun 2007
-
-$1.58 M(-40.0%)
-$14.73 M(-30.6%)
Mar 2007
-
-$2.63 M(-34.2%)
-$21.22 M(-17.0%)
Dec 2006
-$25.57 M(+25.0%)
-$3.99 M(-39.1%)
-$25.57 M(-3.1%)
Sep 2006
-
-$6.55 M(-18.8%)
-$26.39 M(+4.2%)
Jun 2006
-
-$8.06 M(+15.5%)
-$25.32 M(+17.0%)
Mar 2006
-
-$6.98 M(+45.2%)
-$21.65 M(+7.4%)
Dec 2005
-$20.45 M(+41.7%)
-$4.80 M(-12.3%)
-$20.15 M(-1.8%)
Sep 2005
-
-$5.48 M(+25.0%)
-$20.51 M(+7.4%)
Jun 2005
-
-$4.39 M(-20.0%)
-$19.09 M(+6.9%)
Mar 2005
-
-$5.48 M(+6.1%)
-$17.86 M(+23.7%)
Dec 2004
-$14.44 M(+45.1%)
-$5.17 M(+27.2%)
-$14.44 M(+27.9%)
Sep 2004
-
-$4.06 M(+28.7%)
-$11.28 M(+20.3%)
Jun 2004
-
-$3.15 M(+53.5%)
-$9.38 M(+2.6%)
Mar 2004
-
-$2.06 M(+2.0%)
-$9.14 M(-8.1%)
Dec 2003
-$9.95 M(-47.1%)
-$2.01 M(-6.6%)
-$9.95 M(+25.4%)
Sep 2003
-
-$2.16 M(-26.1%)
-$7.93 M(+37.3%)
Jun 2003
-
-$2.92 M(+2.0%)
-$5.78 M(+102.0%)
Mar 2003
-
-$2.86 M
-$2.86 M
Dec 2002
-$18.80 M(+134.8%)
-
-
Dec 2001
-$8.01 M
-
-

FAQ

  • What is Corcept Therapeutics Incorporated annual EBITDA?
  • What is the all time high annual EBITDA for Corcept Therapeutics Incorporated?
  • What is Corcept Therapeutics Incorporated annual EBITDA year-on-year change?
  • What is Corcept Therapeutics Incorporated quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Corcept Therapeutics Incorporated?
  • What is Corcept Therapeutics Incorporated quarterly EBITDA year-on-year change?
  • What is Corcept Therapeutics Incorporated TTM EBITDA?
  • What is the all time high TTM EBITDA for Corcept Therapeutics Incorporated?
  • What is Corcept Therapeutics Incorporated TTM EBITDA year-on-year change?

What is Corcept Therapeutics Incorporated annual EBITDA?

The current annual EBITDA of CORT is $138.29 M

What is the all time high annual EBITDA for Corcept Therapeutics Incorporated?

Corcept Therapeutics Incorporated all-time high annual EBITDA is $138.29 M

What is Corcept Therapeutics Incorporated annual EBITDA year-on-year change?

Over the past year, CORT annual EBITDA has changed by +$28.64 M (+26.12%)

What is Corcept Therapeutics Incorporated quarterly EBITDA?

The current quarterly EBITDA of CORT is $25.72 M

What is the all time high quarterly EBITDA for Corcept Therapeutics Incorporated?

Corcept Therapeutics Incorporated all-time high quarterly EBITDA is $47.10 M

What is Corcept Therapeutics Incorporated quarterly EBITDA year-on-year change?

Over the past year, CORT quarterly EBITDA has changed by -$6.22 M (-19.47%)

What is Corcept Therapeutics Incorporated TTM EBITDA?

The current TTM EBITDA of CORT is $138.29 M

What is the all time high TTM EBITDA for Corcept Therapeutics Incorporated?

Corcept Therapeutics Incorporated all-time high TTM EBITDA is $144.51 M

What is Corcept Therapeutics Incorporated TTM EBITDA year-on-year change?

Over the past year, CORT TTM EBITDA has changed by +$28.64 M (+26.12%)